Strategies for minimizing blood loss in orthopedic surgery.
D015119:Aminocaproic Acid / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000188:drug therapy / Q000209:etiology; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001804:Blood Transfusion, Autologous / Q000009:adverse effects / Q000379:methods*; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D005167:Factor VII / Q000627:therapeutic use; D015942:Factor VIIa; D006438:Hemodilution / Q000379:methods; D006489:Hemostatic Techniques; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D007023:Hypotension, Controlled / Q000379:methods*; D019637:Orthopedic Procedures / Q000009:adverse effects; D011182:Postoperative Care / Q000379:methods; D011300:Preoperative Care / Q000379:methods; D011994:Recombinant Proteins / Q000627:therapeutic use; D014148:Tranexamic Acid / Q000627:therapeutic use
D000933:Antifibrinolytic Agents; D006490:Hemostatics; D011994:Recombinant Proteins; D014148:Tranexamic Acid; D005167:Factor VII; D007611:Aprotinin; C103587:recombinant FVIIa; D015942:Factor VIIa; D003894:Deamino Arginine Vasopressin; D015119:Aminocaproic Acid